Performance of whole blood IFN-
test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10
Authors: Brock I.1; Munk M. E.1; Kok-Jensen A.2; Andersen P.1
Source: The International Journal of Tuberculosis and Lung Disease, Volume 5, Number 5, May 2001 , pp. 462-467(6)
Publisher: International Union Against Tuberculosis and Lung Disease
Abstract:
OBJECTIVE: To evaluate the QuantiFERON-TB® test in BCG-vaccinated, non-BCG-vaccinated and tuberculosis (TB) patient donor groups, and to compare its diagnostic performance with that of a blood test based on the Mycobacterium tuberculosis specific antigens ESAT-6 and CFP-10.
DESIGN: Analysis of the IFN-
responses of whole blood cells from BCG-vaccinated or non-BCG-vaccinated donors or patients with tuberculosis, stimulated with PPD, ESAT-6 or CFP-10 antigens, and evaluation of the specificity and sensitivity of the test.
RESULTS: None of the non-vaccinated donors showed positive responses to M. tuberculosis-PPD, ESAT-6 or CFP-10. In BCG-vaccinated donors, 9/19 (47%) donors responded to the QuantiFERON-TB® test based on M. tuberculosis-PPD, whereas 2/19 (10.5%) responded to either ESAT-6 or CFP-10. Comparable levels of sensitivity were obtained with the QuantiFERON-TB® test based on M. tuberculosis-PPD (79%) and ESAT-6 or CFP-10 antigens (72%).
CONCLUSION: Our results demonstrate that the whole blood test based on M. tuberculosis-PPD did not efficiently distinguish BCG-vaccinated donors from individuals with disease due to M. tuberculosis. The introduction of new recombinant antigens specific for M. tuberculosis, such as ESAT-6 or CFP-10, should increase the specificity of the whole blood test and enable discrimination between TB infection, atypical mycobacterial reactivity and reactivity due to BCG vaccination. Such a test would provide a quantum improvement over the current practice of using the tuberculin skin test for TB control and elimination.
Keywords:
M. tuberculosis;
tuberculosis;
tuberculosis diagnosis;
whole blood test: IFN-
Language: English
Document Type: Regular paper
Affiliations: 1: Department of Tuberculosis Immunology, Statens Serum Institute, Copenhagen, Denmark 2: Department of Pulmonary Medicine, Rigshospitalet, Copenhagen, Denmark


Click here for Page Help